[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” admin_label=”Hero” _builder_version=”3.23.3″ use_background_color_gradient=”on” background_color_gradient_start=”rgba(255,255,255,0)” background_color_gradient_end=”rgba(1,77,183,0.9)” background_color_gradient_type=”radial” background_color_gradient_direction_radial=”top right” background_color_gradient_start_position=”20%” background_color_gradient_overlays_image=”on” background_image=”http://forchronic.com/wp-content/uploads/2019/06/pharmacy-20.jpg” custom_padding=”110px|0px|160px|0px|false|false” custom_padding_tablet=”50px||50px||true” custom_padding_phone=”|||” bottom_divider_style=”asymmetric” bottom_divider_color=”#ffffff” bottom_divider_height=”50px” bottom_divider_flip=”horizontal” bottom_divider_height_tablet=”90px” bottom_divider_height_phone=”80px”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”3.25″ custom_width_px=”1280px”][et_pb_column type=”2_3″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ text_font=”Montserrat||||||||” text_text_color=”rgba(255,255,255,0.7)” text_font_size=”20px” text_line_height=”1.8em” header_font=”Montserrat|700|||||||” header_font_size=”44px” header_line_height=”1.4em” header_6_font=”Montserrat|600||on|||||” header_6_text_color=”rgba(255,255,255,0.7)” header_6_font_size=”16px” header_6_letter_spacing=”2px” header_6_line_height=”1.5em” background_layout=”dark” max_width=”780px” text_font_size_tablet=”” text_font_size_phone=”15px” text_font_size_last_edited=”on|phone” header_font_size_tablet=”” header_font_size_phone=”28px” header_font_size_last_edited=”on|phone”]

Products

 [/et_pb_text][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Cancer de Colon” module_id=”colon” _builder_version=”3.25.3″ background_color=”#8ab6f7″ use_background_color_gradient=”on” background_color_gradient_start=”rgba(138,182,247,0.3)” background_color_gradient_end=”#8ab6f7″ background_color_gradient_end_position=”56%” background_color_gradient_overlays_image=”on” background_image=”http://forchronic.com/wp-content/uploads/2019/05/pharmacy-12-1.jpg” custom_margin=”|5%||5%||true” custom_padding=”|0px|0px|||”][et_pb_row use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”100%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” min_height=”255px” custom_margin=”|auto||7px||” custom_padding=”|0px||||” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb title=”NUTRACEUTICAL – COLON CANCER” url=”#” content_max_width=”1200px” admin_label=”NUTRACÉUTICO – CÁNCER DE COLON” _builder_version=”3.25.3″ header_font=”Montserrat|600|||||||” header_text_align=”center” header_text_color=”rgba(1,77,183,0.9)” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_layout=”dark” custom_margin=”|||||false” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”||||true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_intensity_fold=”30%” animation=”off” header_font_size_last_edited=”off|desktop” border_radii=”on|6px|6px|6px|6px” locked=”off”]Enhancing treatment of Gold Standard therapy in colorectal cancer.

Forchronic has developed a validated nutritional supplement in the context of precision nutrition, formulated from rosemary extract, with supercritical extraction, which has immunomodulatory and anti-inflammatory activity, and which inhibits the synthesis of DNA and lipid metabolism at the molecular level and, consequently, inhibits cell proliferation as well as the migration of tumor cells (metastasis) in colon cancer.[/et_pb_blurb][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”on|off|off” admin_label=”Cancer de Colon” _builder_version=”4.0.3″ background_color=”#8ab6f7″ background_color_gradient_direction=”0deg” custom_margin=”|5%||5%||true” custom_padding=”10px||0px|||” border_radii=”on|10px|10px|10px|10px”][et_pb_row use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” disabled_on=”on|off|off” module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ background_color=”#ffffff” width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto||” custom_padding=”0px||0px|||true” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/formula-colon.jpg” align=”center” _builder_version=”3.23.3″ custom_margin=”||”][/et_pb_image][/et_pb_column][/et_pb_row][et_pb_row use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”100%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||7px||” custom_padding=”|0px||||” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb url=”#” content_max_width=”1200px” admin_label=”NUTRACÉUTICO – CÁNCER DE COLON” module_id=”colon” _builder_version=”3.23.3″ header_font=”Montserrat|600|||||||” header_text_align=”center” header_text_color=”rgba(1,77,183,0.9)” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_layout=”dark” custom_margin=”|||||false” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”||||true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_intensity_fold=”30%” animation=”off” header_font_size_last_edited=”off|desktop” border_radii=”on|6px|6px|6px|6px” locked=”off”]The formula of this compound contains a lipid carrier of high bioactivity, which allows to approach therapeutic strategies for cancer through similar products in the food field and therefore, considered nutritional supplements and not drugs. This lipid carrier increases the bioavailability of the active ingredients, improving the stability of the product during digestion and its bioavailability.

 

The formulation strategy for bioactive carrier lipids is exclusive of Forchronic, which bases it on the development of new precision nutrition products and specific use for health.

 

Current phase: in clinical trials.[/et_pb_blurb][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ background_color=”#ffffff” width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_padding=”|0.4%||0.4%||true”][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”4.0.3″][/et_pb_image][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”4.0.3″][/et_pb_image][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”4.0.3″][/et_pb_image][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”4.0.3″][/et_pb_image][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/FASE-ACTUAL-azul.png” _builder_version=”4.0.3″][/et_pb_image][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_5,1_5,3_5″ use_custom_gutter=”on” gutter_width=”1″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ background_color=”#0c71c3″ width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”||||false|true” custom_padding=”0px|0%|0px|0%|false|true” border_width_all=”2px”][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_text_color=”#ffffff” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_margin=”||||false|false” custom_padding=”0px||0px||true|true” border_color_all=”rgba(0,0,0,0)” border_width_right=”1px” border_color_right=”#000000″]

Development of the Bioactive Suplement

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_text_color=”#ffffff” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_margin=”||||false|false” custom_padding=”0px||0px||true|true” border_color_all=”rgba(0,0,0,0)” border_width_right=”1px” border_color_right=”#000000″]

Preclinical Phase

 [/et_pb_text][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_text_color=”#ffffff” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_margin=”||||false|false” custom_padding=”2%||2%||true|true” border_color_all=”rgba(0,0,0,0)” border_width_right=”1px” border_color_right=”#000000″]

Clinical Trials

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ use_custom_gutter=”on” gutter_width=”1″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ background_color=”#e0e0e0″ width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” custom_padding=”0px||0px||false|true” border_width_all=”1px”][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”11%|5%|11%|5%|true|true” border_width_all=”1px” border_color_bottom=”rgba(0,0,0,0)”]

Lab studies

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”11%|5%|11%|5%|true|true” border_width_all=”1px” border_color_bottom=”rgba(0,0,0,0)”]

Assays in animals

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”10px|4%|10px|4%|true|true” border_width_all=”1px” border_color_bottom=”rgba(0,0,0,0)”]

Clinical trial in healthy volunteers

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”10px|4%|10px|4%|true|true” border_width_all=”1px” border_color_bottom=”rgba(0,0,0,0)”]

Pilot study in phase 0/I

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”10px|4%|10px|4%|true|true” border_width_all=”1px” border_color_bottom=”rgba(0,0,0,0)”]

Clinical trial in phase II/III

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ use_custom_gutter=”on” gutter_width=”1″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ background_color=”#ffffff” width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” custom_padding=”0px||0px||false|true” border_width_all=”3px”][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.6em” custom_margin=”||13px|||” custom_padding=”13.5%|4%||4%|false|true” border_width_all=”1px” border_color_top=”rgba(0,0,0,0)” border_color_bottom=”#ffffff”]

Identification of the compound

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” custom_margin=”||-1px|||” custom_padding=”19px|4%|19px|4%|true|true” border_width_all=”1px” border_color_top=”#ffffff” border_color_bottom=”#ffffff”]

Development of
the compound

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.6em” custom_margin=”||-1px|||” custom_padding=”13.5%|4%||4%|false|true” border_width_all=”1px” border_color_top=”rgba(0,0,0,0)” border_width_bottom=”0px” border_color_bottom=”#ffffff”]

Inhibition of molecular pathways associated with tumor growth

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” custom_margin=”||-1px|||” custom_padding=”4px|4%|4px|4%|true|true” border_width_all=”1px” border_color_top=”#ffffff” border_color_bottom=”#ffffff”]

Potentiation of chemotherapy (fluoropyridines)

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.3em” custom_margin=”||-1px|||” custom_padding=”13.5%|4%||4%|false|true” border_width_all=”1px” border_color_all=”#ffffff” border_color_top=”rgba(0,0,0,0)” border_color_bottom=”#ffffff”]

Made in 60
healthy volunteers

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” custom_margin=”||-1px|||” custom_padding=”4px|4%|4px|4%|true|true” border_width_all=”1px” border_color_all=”#ffffff” border_color_top=”#ffffff” border_color_bottom=”#ffffff”]

Absence of toxicity and potentiation of the immune system

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.3em” custom_margin=”||-1px|||” custom_padding=”13.5%|4%||4%|false|true” border_width_all=”1px” border_color_top=”rgba(0,0,0,0)” border_color_bottom=”#ffffff”]

Made in 11 patients
for 2 weeks

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” custom_margin=”||-1px|||” custom_padding=”4px|4%|4px|4%|true|true” border_width_all=”1px” border_color_top=”#ffffff” border_color_bottom=”#ffffff”]

Verification of tolerability, absence of toxicity and enhancement of the immune system

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.6em” custom_margin=”||-1px|||” custom_padding=”13.5%|4%||4%|false|true” border_width_all=”1px” border_color_top=”rgba(0,0,0,0)” border_color_bottom=”#ffffff”]

Multicenter trial in 150 colon cancer patients receiving chemotherapy (5-Fu)

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_margin=”||-1px|||” custom_padding=”0.1%|4%||4%|false|true” border_width_all=”1px” border_color_top=”rgba(0,0,0,0)” border_color_bottom=”#ffffff”]

Under review by the
ClinicaResearch Ethics
Committee 

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”100%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”12px|auto||7px||” custom_padding=”39px|0px||||” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb url=”#” content_max_width=”1200px” admin_label=”NUTRACÉUTICO – CÁNCER DE COLON” module_id=”colon” _builder_version=”3.23.3″ header_font=”Montserrat|600|||||||” header_text_align=”center” header_text_color=”rgba(1,77,183,0.9)” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_layout=”dark” custom_margin=”|||||false” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”||||true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_intensity_fold=”30%” animation=”off” header_font_size_last_edited=”off|desktop” border_radii=”on|6px|6px|6px|6px” locked=”off”]This new nutritional supplement of Forchronic showed satisfactory results in vitro and in preclinical (animal tests), as well as in a clinical trial in healthy volunteers, where it was demonstrated that there is no sign of toxicity and its association with precision nutrition was shown, identifying the genes and metabolic pathways involved.

In the current phase of clinical trials in patients with colorectal cancer the first positive results have already been obtained.

The preventive, antitumor and immune potentiating properties shown in the trial in healthy volunteers have also been observed in sick patients.

 [/et_pb_blurb][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”off|on|on” admin_label=”Cancer de Colon” _builder_version=”4.0.3″ background_color=”#8ab6f7″ background_color_gradient_direction=”0deg” custom_margin=”|5%||5%||true” custom_padding=”10px||0px|||” border_radii=”on|10px|10px|10px|10px”][et_pb_row column_structure=”3_5,2_5″ use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” disabled_on=”off|on|on” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ background_color=”#ffffff” width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”-43px|auto||auto||” custom_padding=”|5%|0px|5%||true” make_fullwidth=”on”][et_pb_column type=”3_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/formula-colon1.jpg” _builder_version=”3.23.3″ custom_padding=”69px|||||”][/et_pb_image][/et_pb_column][et_pb_column type=”2_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/formula-colon2.jpg” _builder_version=”3.23.3″][/et_pb_image][/et_pb_column][/et_pb_row][et_pb_row use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ width=”100%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” custom_padding=”|0px||||” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb url=”#” content_max_width=”1200px” admin_label=”NUTRACÉUTICO – CÁNCER DE COLON” module_id=”colon” _builder_version=”3.23.3″ header_font=”Montserrat|600|||||||” header_text_align=”center” header_text_color=”rgba(1,77,183,0.9)” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_layout=”dark” custom_margin=”|||||false” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”||||true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_intensity_fold=”30%” animation=”off” header_font_size_last_edited=”off|desktop” border_radii=”on|6px|6px|6px|6px” locked=”off”] 

La fórmula de este compuesto contiene un portador lipídico de elevada bioactividad, que permite abordar estrategias terapéuticas para el cáncer mediante productos similares en el ámbito alimentario y por tanto, considerados complementos nutricionales y no fármacos. Este carrier lipídico aumenta la biodisponibilidad de los principios activos, mejorando la estabilidad del producto durante la digestión y la bioaccesibilidad del mismo.

La estrategia de formulación sobre lípidos portadores bioactivos es exclusiva de Forchronic que basa en ella el desarrollo de nuevos productos de nutrición de precisión y de uso específicos para la salud.

[/et_pb_blurb][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ background_color=”#ffffff” width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_padding=”0px|0.4%||0.4%||true”][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text _builder_version=”4.0.3″ header_3_text_color=”#0c71c3″ header_3_font_size=”24px” background_image=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” min_height=”103px” custom_margin=”7%||||false|false”]

Current status

in clinical trials

 [/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_text_color=”#ffffff” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#0c71c3″ custom_margin=”||2px|||” custom_padding=”10px|5%|10px|5%|true|true” border_width_right=”1px” border_color_right=”#000000″]

Development in Bioactive Suplement

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#e0e0e0″ custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”0px” border_width_bottom=”1px” border_color_bottom=”#000000″]

Lab studies

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”2.1em” custom_margin=”||-1px|||” custom_padding=”6%|4%|6%|4%|true|true”]

Identification of the compound

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.8em” custom_margin=”||-1px|||” custom_padding=”25px|4%|25px|4%|true|true” border_width_bottom=”1px” border_color_bottom=”#000000″]

Development of
the compound

[/et_pb_text][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”4.0.3″ custom_padding=”0px|||||”][/et_pb_image][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_text_color=”#ffffff” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#0c71c3″ custom_padding=”10px|5%|10px|5%|true|true” border_width_right=”1px” border_color_right=”#000000″]

Preclinical Phase

 [/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#e0e0e0″ custom_margin=”-30px|||||” custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”0px” border_width_bottom=”1px” border_color_bottom=”#000000″]

Assays in animals

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.8em” custom_margin=”||-1px|||” custom_padding=”25px|4%|25px|4%|true|true” border_width_all=”0px” border_color_top=”rgba(0,0,0,0)” border_width_bottom=”0px” border_color_bottom=”#000000″]

Inhibition of molecular pathways associated with tumor growth

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” custom_margin=”||-1px|||” custom_padding=”10%|4%|10%|4%|true|true” border_width_all=”0px” border_color_top=”#ffffff” border_width_bottom=”1px” border_color_bottom=”#000000″]

Potentiation of chemotherapy (fluoropyridines)

[/et_pb_text][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”4.0.3″][/et_pb_image][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_text_color=”#ffffff” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#0c71c3″ min_height=”123px” custom_padding=”39px|5%|39px|5%|true|true”]

Clinical Trials 

[/et_pb_text][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#e0e0e0″ custom_margin=”-30px|||||” custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”0px” border_width_bottom=”1px” border_color_bottom=”#000000″]

Clinical trial in healthy volunteers

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.2em” custom_margin=”||||false|false” custom_padding=”1.4%|4%|1.4%|4%|true|true” border_width_all=”1px” border_color_all=”#ffffff” border_color_bottom=”#ffffff”]

Made in 60
healthy volunteers

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” custom_margin=”||-1px|||” custom_padding=”10%|4%|10%|4%|true|true” border_width_all=”0px” border_color_all=”#ffffff” border_color_top=”#ffffff” border_width_bottom=”1px” border_color_bottom=”#000000″]

Absence of toxicity and potentiation of the immune system

[/et_pb_text][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”4.0.3″][/et_pb_image][/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#e0e0e0″ custom_margin=”-30px|||||” custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”0px” border_width_bottom=”1px” border_color_bottom=”#000000″]

Pilot study in phase 0/I

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.2em” custom_margin=”10px||4px||false|false” custom_padding=”2.1%|4%|2.1%|4%|true|true” border_width_all=”1px” border_color_all=”#ffffff” border_color_top=”rgba(0,0,0,0)” border_color_bottom=”#ffffff”]

Made in

11 patients

for 2 weeks

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” custom_margin=”-8px||-1px|||” custom_padding=”10%|4%|10%|4%|true|true” border_width_all=”0px” border_color_all=”#ffffff” border_color_top=”#ffffff” border_width_bottom=”1px” border_color_bottom=”#000000″]

Verification of tolerability, absence of toxicity and enhancement of the immune system

[/et_pb_text][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/FASE-ACTUAL-azul.png” _builder_version=”4.0.3″][/et_pb_image][/et_pb_column][/et_pb_row][et_pb_row use_custom_gutter=”on” gutter_width=”1″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ background_color=”#e0e0e0″ width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” custom_padding=”0px||0px||false|true” border_width_all=”0px”][et_pb_column type=”4_4″ _builder_version=”4.0.3″][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” background_color=”#e0e0e0″ custom_margin=”-30px|||||” custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”0px” border_width_bottom=”1px” border_color_bottom=”#000000″]

Clinical trial in phase II/III

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.7em” background_color=”#ffffff” custom_margin=”||-1px|||” custom_padding=”7px|4%|7px|4%|true|true” border_width_all=”0px” border_color_top=”rgba(0,0,0,0)” border_color_bottom=”#ffffff”]

Multicenter trial in 150 colon cancer patients receiving chemotherapy (5-Fu)

[/et_pb_text][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”4.0.3″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” header_5_line_height=”1.1em” background_color=”#ffffff” custom_margin=”||-1px|||” custom_padding=”7px|4%|7px|4%|true|true” border_width_all=”0px” border_color_all=”#ffffff” border_color_top=”rgba(0,0,0,0)” border_width_bottom=”1px” border_color_bottom=”#ffffff”]

Under review by the Clinica
l Research Ethics Committee

 

Investigación Clínica

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ width=”100%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” custom_padding=”39px|0px||||” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb url=”#” content_max_width=”1200px” admin_label=”NUTRACÉUTICO – CÁNCER DE COLON” module_id=”colon” _builder_version=”3.23.3″ header_font=”Montserrat|600|||||||” header_text_align=”center” header_text_color=”rgba(1,77,183,0.9)” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_layout=”dark” custom_margin=”|||||false” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”||||true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_intensity_fold=”30%” animation=”off” header_font_size_last_edited=”off|desktop” border_radii=”on|6px|6px|6px|6px” locked=”off”]This new nutritional supplement of Forchronic showed satisfactory results in vitro and in preclinical (animal tests), as well as in a clinical trial in healthy volunteers, where it was demonstrated that there is no sign of toxicity and its association with precision nutrition was shown, identifying the genes and metabolic pathways involved.

In the current phase of clinical trials in patients with colorectal cancer the first positive results have already been obtained.

The preventive, antitumor and immune potentiating properties shown in the trial in healthy volunteers have also been observed in sick patients.

 [/et_pb_blurb][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ admin_label=”NUTRACÉUTICO – CÁNCER DE MAMA” _builder_version=”3.23.3″ background_color=”#f9c0cb” use_background_color_gradient=”on” background_color_gradient_start=”rgba(249,192,203,0.3)” background_color_gradient_end=”#f9c0cb” background_color_gradient_end_position=”56%” background_color_gradient_overlays_image=”on” background_image=”http://forchronic.com/wp-content/uploads/2019/05/pharmacy-11.jpg” custom_margin=”3%|5%||5%|false|true” border_radii=”on|10px|10px|10px|10px”][et_pb_row use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ width=”100%” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_margin=”|auto||7px||” custom_padding=”|0px||||” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb title=”NUTRACEUTICAL – BREAST CANCER” content_max_width=”1200px” admin_label=”NUTRACÉUTICO – CÁNCER DE MAMA” module_id=”colon” _builder_version=”4.0.3″ header_font=”Montserrat|600|||||||” header_text_align=”center” header_text_color=”rgba(1,77,183,0.9)” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_layout=”dark” custom_margin=”|||||false” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”||||true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_intensity_fold=”30%” animation=”off” header_font_size_last_edited=”off|desktop” border_radii=”on|6px|6px|6px|6px” locked=”off”]

Development of the nutritional supplement based on rosemary extract with therapeutic activity in breast cancer.

Current phase: start phase II / III of clinical trials in 100 patients with breast cancer at the beginning of 2020.

[/et_pb_blurb][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” gutter_width=”2″ custom_padding_last_edited=”off|desktop” module_class=” et_pb_row_fullwidth” _builder_version=”3.25″ background_color=”#ffffff” width=”1200px” width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” max_width=”94%” max_width_tablet=”80%” max_width_phone=”” max_width_last_edited=”on|desktop” custom_padding=”|5%||5%||true” make_fullwidth=”on”][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”3.23.3″][/et_pb_image][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”3.27.4″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”1px”]

Development in Bioactive Suplement

[/et_pb_text][/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”3.23.3″][/et_pb_image][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”3.27.4″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”10px|4%|10px|4%|true|true” border_width_all=”1px”]

In vitro assays / preclinical phase

[/et_pb_text][/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/flecha-azul.png” _builder_version=”3.23.3″][/et_pb_image][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”3.27.4″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”1px”]

Clinical Trial with Healthy volunteers

[/et_pb_text][/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”http://forchronic.com/wp-content/uploads/2019/06/FASE-ACTUAL-azul.png” _builder_version=”3.23.3″][/et_pb_image][et_pb_text ul_position=”inside” ul_item_indent=”10%” _builder_version=”3.27.4″ ul_font=”||||||||” ul_text_align=”left” ul_text_color=”#000000″ ul_font_size=”16px” header_4_font=”|700|||||||” header_4_text_align=”center” header_4_font_size=”20px” header_4_line_height=”1.5em” custom_padding=”10px|5%|10px|5%|true|true” border_width_all=”1px” box_shadow_style=”preset5″ box_shadow_color=”rgba(12,113,195,0.22)”]

Clinical Trial in Patients

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ admin_label=”NUTRACÉUTICO – CÁNCER DE MAMA” _builder_version=”3.23.3″ custom_margin=”|5%||5%||true” custom_padding=”2%|||||”][et_pb_row custom_padding_last_edited=”off|desktop” module_id=”colon” module_class=” et_pb_row_fullwidth” _builder_version=”4.0.3″ width=”100%” width_tablet=”80%” width_phone=”100%” width_last_edited=”on|desktop” max_width=”100%” max_width_tablet=”80%” max_width_phone=”373%” max_width_last_edited=”on|desktop” custom_margin=”|auto||auto|false|false” custom_padding=”|0px||0px|false|false” make_fullwidth=”on”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb title=”NUTRACEUTICAL – OTHER TUMORS” content_max_width=”1200px” module_id=”otros” _builder_version=”4.0.3″ header_font=”Montserrat|600|||||||” header_text_align=”left” header_text_color=”#ff9900″ header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_align=”left” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_color=”#fccc88″ use_background_color_gradient=”on” background_color_gradient_start=”rgba(252,204,136,0.3)” background_color_gradient_end=”#fccc88″ background_color_gradient_end_position=”56%” background_color_gradient_overlays_image=”on” background_image=”http://forchronic.com/wp-content/uploads/2019/05/pharmacy-09-1.jpg” text_orientation=”center” background_layout=”dark” custom_margin=”|||||” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”2%|5%|2%|5%|true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_delay=”300ms” animation_intensity_fold=”30%” animation=”off” border_radii=”on|6px|6px|6px|6px” locked=”off”]

Applicability of the nutraceutical product based on rosemary extract and carried in the lipid vehicle of high bioactivity in other types of tumors, such as lung cancer.

Current phase: start phase II / III of clinical trials in 50 patients with lung cancer at the beginning of 2020.

[/et_pb_blurb][et_pb_blurb title=”NUTRACEUTICAL – AUTOIMMUNE DISEASES:” content_max_width=”1200px” module_id=”autoinmunes” _builder_version=”4.0.3″ header_font=”Montserrat|600|||||||” header_text_align=”left” header_text_color=”#ffffff” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_align=”left” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_color=”#fccc88″ use_background_color_gradient=”on” background_color_gradient_start=”rgba(131,0,233,0.5)” background_color_gradient_end=”rgba(131,0,233,0.31)” background_color_gradient_type=”radial” background_color_gradient_direction_radial=”right” background_color_gradient_start_position=”20%” background_color_gradient_overlays_image=”on” background_image=”http://forchronic.com/wp-content/uploads/2019/05/pharmacy-16.jpg” text_orientation=”center” background_layout=”dark” custom_margin=”|||||” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”2%|5%|2%|5%|true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_delay=”300ms” animation_intensity_fold=”30%” animation=”off” border_radii=”on|6px|6px|6px|6px” locked=”off”]Study and development of the nutritional compound based on rosemary carried in the patented lipid carrier for the treatment of autoimmune diseases such as Rheumatoid Arthritis, Type I Diabetes, Psoriasis, Celiac Disease and Multiple Sclerosis.

Current phase: clinical trials in healthy volunteers.[/et_pb_blurb][et_pb_blurb title=”NEWS NUTRACEUTICAL PRODUCTS” url=”#” content_max_width=”1200px” module_id=”autoinmunes” _builder_version=”4.0.3″ header_font=”Montserrat|600|||||||” header_text_align=”left” header_text_color=”#ffffff” header_font_size=”31px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_align=”left” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.8em” background_color=”#fccc88″ use_background_color_gradient=”on” background_color_gradient_start=”rgba(124,218,36,0.34)” background_color_gradient_end=”#7cda24″ background_color_gradient_type=”radial” background_color_gradient_direction_radial=”right” background_color_gradient_start_position=”20%” background_color_gradient_overlays_image=”on” background_image=”http://forchronic.com/wp-content/uploads/2019/05/pharmacy-07.jpg” text_orientation=”center” background_layout=”dark” custom_margin=”|||||” custom_margin_tablet=”||30px|” custom_margin_phone=”|||” custom_margin_last_edited=”off|desktop” custom_padding=”2%|5%|2%|5%|true|true” custom_padding_last_edited=”off|desktop” animation_style=”fold” animation_delay=”300ms” animation_intensity_fold=”30%” animation=”off” border_radii=”on|6px|6px|6px|6px” locked=”off”]

Extracts of yarrow and calendula for pancreatic cancer, obesity, metabolic syndrome and metabolic diseases.

Current phase: preclinical phase. Forecast to clinical trial in human volunteers for extract of yarrow.

[/et_pb_blurb][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”off|desktop” admin_label=”Footer” _builder_version=”3.23.3″ use_background_color_gradient=”on” background_color_gradient_start=”rgba(1,77,183,0.5)” background_color_gradient_end=”rgba(255,255,255,0)” background_color_gradient_type=”radial” background_color_gradient_direction_radial=”top right” background_color_gradient_overlays_image=”on” background_image=”http://forchronic.com/wp-content/uploads/2019/05/pharmacy-06.jpg” custom_padding=”100px||100px||true” top_divider_style=”asymmetric” top_divider_color=”#ffffff” top_divider_height=”50px” top_divider_flip=”vertical|horizontal” top_divider_arrangement=”above_content” saved_tabs=”all”][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”3.25″][et_pb_column type=”1_3″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb title=”Phone” use_icon=”on” font_icon=”%%264%%” icon_color=”#ffffff” use_circle=”on” circle_color=”rgba(1,77,183,0.9)” use_icon_font_size=”on” icon_font_size=”20px” _builder_version=”4.8.2″ header_font=”Montserrat||||||||” header_text_color=”#ffffff” header_font_size=”19px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”rgba(1,77,183,0.9)” body_font_size=”16px” body_line_height=”1.5em” text_orientation=”center” background_layout=”dark” custom_margin=”|||” custom_padding=”|||” header_text_shadow_style=”preset1″ border_radii=”on|10px|10px|10px|10px” locked=”off”]

(+34) 91 104 46 75

(+34) 91 104 46 76

[/et_pb_blurb][et_pb_blurb title=”Address” use_icon=”on” font_icon=”%%249%%” icon_color=”#ffffff” use_circle=”on” circle_color=”rgba(1,77,183,0.9)” use_icon_font_size=”on” icon_font_size=”20px” _builder_version=”4.8.2″ header_font=”Montserrat||||||||” header_text_color=”#ffffff” header_font_size=”19px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”rgba(1,77,183,0.9)” body_font_size=”16px” body_line_height=”1.5em” text_orientation=”center” background_layout=”dark” custom_margin=”|||” custom_padding=”|||” header_text_shadow_style=”preset1″ border_radii=”on|10px|10px|10px|10px” locked=”off”]Av. Industria, nº 4, building 1
Ground floor, office D
28108, Alcobendas, MADRID[/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb title=”Email” use_icon=”on” font_icon=”%%238%%” icon_color=”#ffffff” use_circle=”on” circle_color=”rgba(1,77,183,0.9)” use_icon_font_size=”on” icon_font_size=”20px” _builder_version=”3.23.3″ header_font=”Montserrat||||||||” header_text_color=”#ffffff” header_font_size=”19px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”rgba(1,77,183,0.9)” body_font_size=”16px” body_line_height=”1.5em” body_link_font=”||||||||” text_orientation=”center” background_layout=”dark” custom_margin=”|||” custom_padding=”|||” link_option_url=”mailto:administracion@canaanrd.com” header_text_shadow_style=”preset1″ body_link_text_shadow_style=”preset1″ border_radii=”on|10px|10px|10px|10px” locked=”off”]administracion@canaanrd.com[/et_pb_blurb][et_pb_blurb title=”Office Hours” use_icon=”on” font_icon=”%%227%%” icon_color=”#ffffff” use_circle=”on” circle_color=”rgba(1,77,183,0.9)” use_icon_font_size=”on” icon_font_size=”20px” _builder_version=”3.23.3″ header_font=”Montserrat||||||||” header_text_color=”#ffffff” header_font_size=”19px” header_line_height=”1.5em” body_font=”Montserrat||||||||” body_text_color=”rgba(1,77,183,0.9)” body_font_size=”16px” body_line_height=”1.5em” text_orientation=”center” background_layout=”dark” custom_margin=”|||” custom_padding=”|||” header_text_shadow_style=”preset1″ border_radii=”on|10px|10px|10px|10px” locked=”off”]Monday – Friday

8:15 – 16:45[/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.0.3″ text_font=”||||||||” link_font=”||||||||” link_text_color=”#1158BB” link_font_size=”16px” link_line_height=”2em” header_font=”||||||||” header_3_font=”|||on|||||” header_3_text_color=”#1158BB” header_3_font_size=”20px” width=”100%” custom_margin=”5%||” link_text_shadow_style=”preset1″ header_3_text_shadow_style=”preset1″]

Links of Interest

http://canaanrd.com/index.html
www.mirnaxbiosens.com
www.isquaemiabiotech.com
www.dermainnovate.com
www.food.imdea.org/
https://www.cial.uam-csic.es/pagperso/ingredientes_alim_bioactivos/

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]